Cancer gene therapy steadily advances.
Brower
Vicki
V
D000256:Adenoviridae; D000818:Animals; D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D017326:Clinical Trials, Phase III as Topic; D056746:Cyclin G; D056766:Cyclin G1; D016213:Cyclins / Q000009:adverse effects / Q000737:chemistry / Q000494:pharmacology*; D018014:Gene Transfer Techniques; D016158:Genes, p53; D015316:Genetic Therapy / Q000009:adverse effects / Q000379:methods / Q000639:trends; D005822:Genetic Vectors; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D008198:Lymph Nodes / Q000821:virology; D009369:Neoplasms / Q000235:genetics* / Q000473:pathology / Q000628:therapy*; D009474:Neurons / Q000821:virology; D012449:Safety; D018139:Simplexvirus; D014765:Viral Vaccines / Q000494:pharmacology*
C534702:CCNG1 protein, human; D056746:Cyclin G; D056766:Cyclin G1; D016213:Cyclins; D014765:Viral Vaccines; C512972:advexin